Your browser doesn't support javascript.
loading
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki, Kana; Sakai, Rika; Iwaki, Noriko; Yamamoto, Go; Murayama, Kayoko; Nishikori, Momoko; Sunami, Kazutaka; Yoshida, Isao; Yano, Hiroki; Takahashi, Naoki; Okamoto, Akinao; Munemoto, Saori; Sawazaki, Aiko; Suehiro, Youko; Fukuhara, Noriko; Wake, Atsushi; Arai, Ayako; Masaki, Yasufumi; Toyama, Kohtaro; Yokoyama, Akihiro; Tsunemine, Hiroko; Hasegawa, Yuichi; Matsumoto, Kenji; Yamada, Tomomi; Nishimura, Yuki; Tamaru, Satoshi; Asano, Naoko; Miyawaki, Kohta; Izutsu, Koji; Kinoshita, Tomohiro; Suzuki, Ritsuro; Ohshima, Koichi; Kato, Koji; Katayama, Naoyuki; Yamaguchi, Motoko.
Afiliação
  • Miyazaki K; Mie University, Tsu, Japan.
  • Sakai R; Kanagawa Cancer Center, Yokohama, Japan.
  • Iwaki N; Kanazawa University, Kanazawa, Japan.
  • Yamamoto G; Toranomon Hospital, Tokyo, Japan.
  • Murayama K; Gunma Cancer Center, Ohta, Japan.
  • Nishikori M; Kyoto University, Kyoto, Japan.
  • Sunami K; Okayama Medical Center, Okayama, Japan.
  • Yoshida I; Shikoku Cancer Center, Matsuyama, Japan.
  • Yano H; Kainan Hospital, Yatomi, Japan.
  • Takahashi N; Saitama Medical University, Hidaka, Japan.
  • Okamoto A; Fujita Medical University, Toyoake, Japan.
  • Munemoto S; Keiju Medical Center, Kanazawa, Japan.
  • Sawazaki A; Fukui-ken Saiseikai Hospital, Fukui, Japan.
  • Suehiro Y; Kyushu Cancer Center, Fukuoka, Japan.
  • Fukuhara N; Tohoku University, Sendai, Japan.
  • Wake A; Toranomon Hospital Kajigaya, Kajigaya, Japan.
  • Arai A; St. Marianna University, Kawasaki, Japan.
  • Masaki Y; Kanazawa Medical University, Ishikawa, Japan.
  • Toyama K; Fujioka General Hospital, Fujioka, Japan.
  • Yokoyama A; Tokyo Medical Center, Tokyo, Japan.
  • Tsunemine H; Shinko Hospital, Kobe, Japan.
  • Hasegawa Y; University of Tsukuba, Tsukuba, Japan.
  • Matsumoto K; Yokohama City University, Yokohama, Japan.
  • Yamada T; Osaka University, Suita, Japan.
  • Nishimura Y; Mie University, Tsu, Japan.
  • Tamaru S; Mie University, Tsu, Japan.
  • Asano N; Shinshu Medical Center, Suzaka, Japan.
  • Miyawaki K; Kyushu University, Fukuoka, Japan.
  • Izutsu K; National Cancer Center Hospital, Tokyo, Japan.
  • Kinoshita T; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Suzuki R; Shimane University, Izumo, Japan.
  • Ohshima K; Kurume University, Kurume, Japan.
  • Kato K; Kyushu University, Fukuoka, Japan.
  • Katayama N; Mie University, Tsu, Japan.
  • Yamaguchi M; Mie University, Tsu, Japan.
Cancer Sci ; 114(6): 2689-2691, 2023 06.
Article em En | MEDLINE | ID: mdl-36929591
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão